Characterization of the activation function-2 domain of the human 1,25-dihydroxyvitamin D3 receptor

Molecular and Cellular Endocrinology

Volumn 139, Issue 1-2, 1998, Pages 15-24

  Nakajima, Shigeo ^a   Yamagata, Masayo ^a   Sakai, Norio ^a   Ozono, Keiichi ^a  

^a RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

Author keywords

AF 2; Dominant negative effect; Transcriptional activation; Vitamin D receptor

Indexed keywords

CALCITRIOL; CALCITRIOL RECEPTOR; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; MUTANT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION; TRANSACTIVATION;

EID: 0032580292     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00077-X     Document Type: Article

References (40)

1. Baker A.R., McDonnell D.P., Hughes M., Crisp T.M., Mangelsdorf D.J., Haussler M.R., Pike J.W., Shine J., O'Malley B.W. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. USA. 85:1988;3294-3298.
2. Baniahmad A., Leng X., Burris T.P., Tsai S.Y., Tsai M.-J., O'Malley B.W. The τ4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol. Cell. Biol. 15:1995;76-86.
3. Barettino D., Ruiz M.M.V., Stunnenberg H.G. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J. 13:1994;3039-3049.
4. Blanco J.C.G., Wang I.-M., Tsai S.Y., Tsai M.-J., O'Malley B.W., Jurutka P.W., Haussler M.R., Ozato K. Transcriptional factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. Proc. Natl. Acad. Sci. USA. 92:1995;1535-1539.
5. Chakravarti D., LaMorte V.J., Nelson M.C., Nakajima T., Schulman I.G., Juguilon H., Montmity M., Evans R.M. Role of CBP/p300 in nuclear receptor signalling. Nature. 383:1996;99-102.
6. Damm K., Heyman R.A., Umesono K., Evans R.M. Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants. Proc. Natl. Acad. Sci. USA. 90:1993;2989-2993.
7. Durand B., Saunders M., Gaudon C., Roy B., Losson R., Chambon P. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J. 13:1994;5370-5382.
8. Giguere V., Ong E.S., Segui P., Evans R.M. Identification of a receptor for the morphogen retinoic acid. Nature. 330:1987;624-629.
9. Greene G.L., Gilna P., Waterfield M., Baker A., Hort Y., Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science. 231:1986;1150-1154.
10. Haussler M.R., Mangelsdorf D.J., Komm B.S., Terpening C.M., Yamaoka K., Allegretto E.A., Baker A.R., Shine J., McDonnell D.P., Hughes M., Weigel N.L., O'Malley B.W., Pike J.W. Molecular biology of the vitamin D hormone. Recent Prog. Horm. Res. 44:1988;263-305.
11. Haussler M.R., Mangelsdorf D.J., Yamaoka K., Allegretto E.A., Komm B.S., Terpening C.M., McDonnell D.P., Pike J.W., O'Malley B.W. Molecular characterization and actions of the vitamin D hormone receptor. Ringold G. Steroid Hormone Action. 1988;247-262 Alan R. Liss, New York.
12. Hong H., Kohli L., Trivedi A., Johnson D.L., Stallcup M.R. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc. Natl. Acad. Sci. USA. 93:1996;4948-4952.
13. Hörlein A.J., Näär A.M., Heinzel T., Torchia J., Gloss B., Kurokawa R., Ryan A., Kamei Y., Söderström M., Galss C.K., Rosenfeld M.G. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature. 377:1995;397-404.
14. Ince B.A., Zhuang Y., Wrenn C.K., Sapiro D.J., Katzenellenbogen B.S. Powerful dominant negative mutants of the human estrogen receptor. J. Biol. Chem. 268:1993;14026-14032.
15. 3 receptor identifying C-terminal amino acids required for transcriptional activation that are functionally dissociated from hormone binding, heterodimeric DNA binding, and interaction with basal transcriptional factor IIB, in vitro. J. Biol. Chem. 272:1997;14592-14599.
16. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S.-C., Heyman R.A., Rose D.W., Glass C.K., Rosenfeld M.G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 85:1996;403-414.
17. 3 signaling. Nature. 355:1992;446-449.
18. Kwok R.P.S., Lundblad J.R., Chrivia J.C., Richards J.P., Bächinger H.P., Brennan R.G., Roberts S.G.E., Green M.R., Goodman R.H. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature. 370:1994;223-226.
19. LeDouarin B., Zechel C., Garnier J.M., Lutz Y., Tora L., Pierrat B., Heery D., Gronenmeyer H., Chambon P., Losson R. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. ENBO J. 14:1995;2020-2033.
20. 3. Proc. Natl. Acad. Sci. USA. 87:1990;9751-9755.
21. 3 analogues and their 20-epi homologues with the vitamin D receptor. J. Biol. Chem. 272:1997;3336-3345.
22. 3-activated expression of the rat osteocalcin gene. Mol. Cell. Biol. 13:1993;5907-5917.
23. MacDonald P.N., Sherman D.R., Dowd D.R., Jefcoat S.C., DeLisle R.K. The vitamin D receptor interacts with general transcriptional factor IIB. J. Biol. Chem. 270:1995;4748-4752.
24. Malik S., Hisatake K., Sumimoto H., Horikoshi M., Roeder R.G. Sequence of general transcription factor TFIIB and relationships to other initiation factors. Proc. Natl. Acad. Sci. USA. 88:1991;9553-9557.
25. Mangelsdorf D.J., Ong E.S., Dyck J.A., Evans R.M. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature. 345:1990;224-229.
26. Nakajima S., Hsieh J.-C., MacDonald P.N., Galligan M.A., Haussler C.A., Whitfield G.K., Haussler M.R. The C-terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vitamin D responsive element. Mol. Endocrinol. 8:1994;159-172.
27. 3 receptor. J. Biol. Chem. 271:1996;5143-5149.
28. Oñate S.A., Tsai S.Y., Tsai M.-J., O'Malley B.W. Sequence and characterization of a coactivator for steroid hormone receptor superfamily. Science. 270:1995;1354-1357.
29. 3. J. Bone Miner. Res. 6:1991;1021-1027.
30. 3 are associated with enhanced activation of the vitamin D receptor. J. Biol. Chem. 270:1995;10551-10558.
31. Pham T.A., Hwung Y.-P., Santiso-Mere D., McDonnell D.P., O'Malley B.W. Ligand-dependent and -independent function of the transactivation regions of the human estrogen receptor in yeast. Mol. Endocrinol. 6:1992;1043-1050.
32. Renaud J.-P., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H., Moras D. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature. 378:1995;681-689.
33. Smith C.L., Oñate S.A., Tsai M.-J., O'Malley B.W. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc. Natl. Acad. Sci. USA. 93:1996;8884-8888.
34. 3-modulated heterodimer. J. Biol. Chem. 266:1991;23296-23305.
35. Voegel J.J., Heine M.J.S., Zeckel C., Chambon P., Gronemeyer H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15:1996;3667-3675.
36. Wagner R.L., Apriletti J.W., McGrath M.E., West B.L., Baxter J.D., Fletterick R.J. A structural role for hormone in the thyroid hormone receptor. Nature. 378:1995;690-697.
37. Weinberger C., Thompson C.C., Ong E.S., Lebo R., Gruol D.J., Evans R.M. The c-erb-A gene encodes a thyroid hormone receptor. Nature. 324:1986;641-646.
38. Whitfield G.K., Hsieh J.-C., Nakajima S., MacDonald P.N., Thompson P.D., Jurutka P.W., Haussler C.A., Haussler M.R. A highly conserved region in the hormone-binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation. Mol. Endocrinol. 9:1995;1166-1179.
39. Yen P.M., Chin W.W. Molecular mechanisms of dominant negative activity by nuclear receptors. Mol. Endocrinol. 8:1994;1450-1454.
40. Yu V.C., Delsert C., Andersen B., Holloway J.M., Devary O.V., Näär A.M., Kim S.Y., Boutin J.-M., Glass C.K., Rosenfeld M.G. RXRβ: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell. 67:1991;1251-1266.